Skip to content
Certara Drug Interaction Database (DIDB®)
  • Licensing
    • Does my organization have a DIDB® license?
    • Licensing
    • Account policies
  • News
  • Support
  • Contact Us
  • Sign in
September 16, 2022 |  News

Data Curation and Entry in DIDB – August Summary

In August, we added 104 citations in DIDB, including 39 in vitro (with 22 articles published in August 2022) and 65 in vivo articles (with 37 articles published in August 2022).

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.

Post navigation

New features! Drug Characteristics queries expanded, and Invite a colleague to use DIDB
Enzyme- and Transporter-Mediated Clinical Drug Interactions with Drugs by the U.S. Food and Drug Administration in 2021: What Can be Learned from New Drug applications Reviews?
Follow us on Linked

Recent News

  • Applications of PBPK for Drugs Approved by the US Food and Drug Administration in 2023 and 2024: A Review of Drug Label Clinical Trial Waivers
  • Metabolite Measurement in Index Substrate Drug Interaction Studies: A Review of the Literature and Recent New Drug Application Reviews
  • Risk of Enzyme- and Transporter-Mediated Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews
  • Pharmacokinetic Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2024: A Review of Clinical Data Available in New Drug Application Reviews
  • Data Curation and Entry in DIDB – September Summary

News Categories

  • Events
  • New features
  • News
  • Posters
  • Publications
  • Blog
  • Contact
  • Privacy
Copyright © 2025 Certara, USA. All Rights Reserved.